Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Clinical Cancer Research

• Publication date

  2001-09-01

• Fields of study

  Medicine

• Identifiers
  PMID 11555602
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interferon Alfa-2b Adjuvant Therapy of High-Risk Resected Cutaneous Melanoma: The Eastern Cooperative Oncology Group Trial EST 1684

  2023cited by this paper
• Immunohistochemical detection of acidic fibroblast growth factor in bladder transitional cell carcinoma

  2004cited by this paper
• Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1.

  2001cited by this paper
• Matrix metalloproteinases: biologic activity and clinical implications.

  2000cited by this paper
• Up-regulation of E-cadherin and I-catenin in human hepatocellular carcinoma cell lines by sodium butyrate and interferon-alpha.

  2000cited by this paper
• Exogenous Expression of N-Cadherin in Breast Cancer Cells Induces Cell Migration, Invasion, and Metastasis

  2000cited by this paper
• Matrix metalloproteinases: multifunctional contributors to tumor progression.

  2000cited by this paper
• Up-regulation of E-cadherin and β-catenin in human hepatocellular carcinoma cell lines by sodium butyrate and interferon-α

  2000cited by this paper
• Regulation of Cell Invasion and Morphogenesis in a Three-Dimensional Type I Collagen Matrix by Membrane-Type Matrix Metalloproteinases 1, 2, and 3

  2000cited by this paper
• Differential expression of E-cadherin and type IV collagenase genes predicts outcome in patients with stage I non-small cell lung carcinoma.

  2000cited by this paper
• Anti-epidermal growth factor receptor antibody C225 inhibits angiogenesis in human transitional cell carcinoma growing orthotopically in nude mice.

  2000cited by this paper
• Relative expression of type IV collagenase, E-cadherin, and vascular endothelial growth factor/vascular permeability factor in prostatectomy specimens distinguishes organ-confined from pathologically advanced prostate cancers.

  2000cited by this paper
• The prognostic value of angiogenesis factor expression for predicting recurrence and metastasis of bladder cancer after neoadjuvant chemotherapy and radical cystectomy.

  2000cited by this paper
• Dominant role of E-cadherin in the progression of bladder cancer.

  1999cited by this paper
• Anti-epidermal growth factor receptor antibody C225 inhibits angiogenesis in human transitional cell carcinoma growing orthotopically in nude mice.

  1999cited by this paper
• Tumor progression and expression of matrix metalloproteinase-2 (MMP-2) mRNA by Human Urinary Bladder Cancer Cells

  1999cited by this paper
• Role of matrix metalloproteinase-9 in the basement membrane destruction of superficial urothelial carcinomas.

  1999cited by this paper
• Relative expression of E-cadherin and type IV collagenase genes predicts disease outcome in patients with resectable pancreatic carcinoma.

  1999cited by this paper
• Urinary vascular endothelial growth factor and its correlation with bladder cancer recurrence rates.

  1999cited by this paper
• Interferon-alpha-mediated down-regulation of angiogenesis-related genes and therapy of bladder cancer are dependent on optimization of biological dose and schedule.

  1999cited by this paper
• Cancer statistics, 1999

  1999cited by this paper
• Increased incidence of matrix metalloproteinases in urine of cancer patients.

  1998cited by this paper
• Prognostic values of matrix metalloproteinase‐2 and tissue inhibitor of metalloproteinase‐2 expression in bladder cancer

  1998cited by this paper
• Tumor progression and expression of matrix metalloproteinase-2 (MMP-2) mRNA by human urinary bladder cancer cells

  1998cited by this paper
• Recombinant human interleukin-2, recombinant human interferon alfa-2a, or both in metastatic renal-cell carcinoma. Groupe Français d'Immunothérapie.

  1998cited by this paper
• Inhibition of basic fibroblast growth factor expression, angiogenesis, and growth of human bladder carcinoma in mice by systemic interferon-alpha administration.

  1998cited by this paper
• Molecular determinants of angiogenesis in cancer metastasis.

  1998cited by this paper
• Angiogenic molecules and cancer metastasis.

  1998cited by this paper
• Antiproliferative activity of interferon α and retinoic acid in SiHa carcinoma cells: The role of cell adhesion

  1998cited by this paper
• Matrix metalloproteinase-9 expression in bladder washes from bladder cancer patients predicts pathological stage and grade.

  1998cited by this paper
• Down-regulation of E-cadherin in mouse skin carcinoma cells enhances a migratory and invasive phenotype linked to matrix metalloproteinase-9 gelatinase expression.

  1998cited by this paper
• Cytokines and thyroid epithelial integrity: interleukin-1alpha induces dissociation of the junctional complex and paracellular leakage in filter-cultured human thyrocytes.

  1998cited by this paper
• Imbalance between serum matrix metalloproteinase-2 and its inhibitor as a predictor of recurrence of urothelial cancer.

  1998cited by this paper
• Recombinant Human Interleukin-2, Recombinant Human Interferon Alfa-2a, or Both in Metastatic Renal-Cell Carcinoma

  1998cited by this paper
• Role of the matrix metalloproteinase and tissue inhibitors of metalloproteinase families in noninvasive and invasive tumors transplanted in mice with severe combined immunodeficiency.

  1998cited by this paper
• Prognostic values of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression in bladder cancer.

  1998cited by this paper
• Expression of E-cadherin and alpha-,beta- and gamma-catenins in human bladder carcinomas: are they good prognostic factors?

  1997cited by this paper
• The Mitogen-activated Protein Kinase and JAK-STAT Signaling Pathways Are Required for an Oncostatin M-responsive Element-mediated Activation of Matrix Metalloproteinase 1 Gene Expression*

  1997cited by this paper
• The role of interferon alfa in the treatment of metastatic melanoma.

  1997cited by this paper
• Basic fibroblast growth factor regulates matrix metalloproteinases production and in vitro invasiveness in human bladder cancer cell lines.

  1997cited by this paper
• Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.

  1996cited by this paper
• Intratumoral heterogeneity and inverse correlation between expression of E-cadherin and collagenase type IV in human gastric carcinomas.

  1996cited by this paper
• High levels of tissue inhibitor of metalloproteinase-2 (TIMP-2) expression are associated with poor outcome in invasive bladder cancer.

  1996cited by this paper
• Cell density-dependent modulation of basic fibroblast growth factor expression by human interferon-beta.

  1996cited by this paper
• DISRUPTION OF CELL—CELL ADHESION IN THE PRESENCE OF SODIUM BUTYRATE ACTIVATES EXPRESSION OF THE 92kDa TYPE IV COLLAGENASE IN MDCK CELLS

  1996cited by this paper
• Transmembrane-deletion Mutants of the Membrane-type Matrix Metalloproteinase-1 Process Progelatinase A and Express Intrinsic Matrix-degrading Activity (*)

  1996cited by this paper
• Elevation of serum levels of matrix metalloproteinase‐2 and ‐3 as new predictors of recurrence in patients with urothelial carcinoma

  1996cited by this paper
• Loss of human E-cadherin (ECD) correlated with invasiveness of transitional cell cancer in the renal pelvis, ureter and urinary bladder.

  1996cited by this paper
• Interferon-beta prevents the upregulation of interleukin-8 expression in human melanoma cells.

  1996influential reference
• Multiparametric in situ mRNA hybridization analysis to predict disease recurrence in patients with colon carcinoma.

  1996cited by this paper
• Prognostic significance of circulating matrix metalloproteinase-2 to tissue inhibitor of metalloproteinases-2 ratio in recurrence of urothelial cancer after complete resection.

  1996cited by this paper
• Cell density-dependent modulation of basic fibroblast growth factor expression by human interferon-β

  1996cited by this paper
• Interferon-β Prevents the Upregulation of Interleukin-8 Expression in Human Melanoma Cells

  1996cited by this paper
• Cell adhesion molecules in bladder cancer: soluble serum E-cadherin correlates with predictors of recurrence.

  1996cited by this paper
• Multiparametric in situ messenger RNA hybridization analysis to detect metastasis-related genes in surgical specimens of human colon carcinomas.

  1995cited by this paper
• Evaluation of Low Dose Alpha-Interferon (Roferon-A®) in Patients with Advanced Renal Cell Carcinoma: A Southwest Oncology Group Study

  1995cited by this paper
• Different angiogenic pathways characterize superficial and invasive bladder cancer.

  1995cited by this paper
• E‐cadherin expression in bladder cancer using formalin‐fixed, paraffin‐embedded tissues: Correlation with histopathological grade, tumour stage and survival

  1995cited by this paper
• Wild-Type p53 Regulates Its Own Transcription in a Cell-Type Specific Manner

  1995cited by this paper
• Interferon-alpha and survival in renal cell cancer.

  1995cited by this paper
• In situ mRNA hybridization technique for analysis of metastasis-related genes in human colon carcinoma cells.

  1995cited by this paper
• Isolation and characterization of metastatic variants from human transitional cell carcinoma passaged by orthotopic implantation in athymic nude mice.

  1995cited by this paper
• Suppression of gelatinase production with decreased invasiveness of choriocarcinoma cells by human recombinant interferon beta.

  1995cited by this paper
• 5-Fluorouracil and interferon-alpha in chemotherapy refractory bladder carcinoma: an effective regimen.

  1994cited by this paper
• The interferons: a biological system with therapeutic potential in viral infections.

  1994cited by this paper
• Monoclonal antibodies specific for endothelial cells of mouse blood vessels. Their application in the identification of adult and embryonic endothelium.

  1994cited by this paper
• Role of interferons in the regulation of cell proliferation, differentiation, and development

  1994cited by this paper
• Significant activity of paclitaxel in advanced transitional-cell carcinoma of the urothelium: a phase II trial of the Eastern Cooperative Oncology Group.

  1994cited by this paper
• Human recombinant interferons‐beta and ‐gamma decrease gelatinase production and invasion by human KG‐2 renal‐carcinoma cells

  1994cited by this paper
• Cytokine therapeutics: lessons from interferon alpha.

  1994cited by this paper
• A rapid colorimetric in situ mRNA hybridization technique using hyperbiotinylated oligonucleotide probes for analysis of mdr1 in mouse colon carcinoma cells.

  1993cited by this paper
• Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion.

  1993cited by this paper
• Molecular cloning and characterization of the human E-cadherin cDNA

  1993cited by this paper
• Expression of basic fibroblast growth factor and its receptor in an invasive bladder carcinoma cell line

  1993cited by this paper
• A rapid colorimetric in situ messenger RNA hybridization technique for analysis of epidermal growth factor receptor in paraffin-embedded surgical specimens of human colon carcinomas.

  1993cited by this paper
• Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas.

  1993cited by this paper
• Complete one-hour immunocytochemistry based on capillary action.

  1992cited by this paper
• Downregulation of interleukin 8 gene expression in human fibroblasts: unique mechanism of transcriptional inhibition by interferon.

  1992influential reference
• Modulation of the invasive phenotype of human colon carcinoma cells by organ specific fibroblasts of nude mice.

  1992cited by this paper
• Interferon alfa‐2a therapy for life‐threatening hemangiomas of infancy

  1992cited by this paper
• Interferon alfa-2a therapy for life-threatening hemangiomas of infancy

  1992cited by this paper
• Interferon Treatments: How to Use an Endogenous System as a Therapeutic Agent

  1992cited by this paper
• Expression of E- and P-cadherin in gastric carcinomas.

  1991cited by this paper
• Prognostic factors for survival of patients with advanced urothelial tumors treated with methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy

  1991cited by this paper
• Effects of interferons and other cytokines on tumors in animals: a review.

  1991cited by this paper
• Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma.

  1991cited by this paper
• Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role.

  1991cited by this paper
• Cadherin cell adhesion receptors as a morphogenetic regulator.

  1991cited by this paper
• Results of contemporary radical cystectomy for invasive bladder cancer: a clinicopathological study with an emphasis on the inadequacy of the tumor, nodes and metastases classification.

  1991cited by this paper
• The interferons. Mechanisms of action and clinical applications.

  1991cited by this paper
• Cadherins: a molecular family important in selective cell-cell adhesion.

  1990cited by this paper
• Neutral metalloproteinases produced by human mononuclear phagocytes. Enzyme profile, regulation, and expression during cellular development.

  1990cited by this paper
• Metalloproteinases and cancer invasion.

  1990cited by this paper
• Cancer statistics

  1989cited by this paper
• A new in vitro assay for quantitating tumor cell invasion.

  1989cited by this paper
• Antitumor effects of interferon.

  1989cited by this paper
• Cadherin cell-adhesion molecules in human epithelial tissues and carcinomas.

  1989cited by this paper
• Treatment of pulmonary hemangiomatosis with recombinant interferon alfa-2a.

  1989cited by this paper
• A new in vitro assay for quantitating tumor cell invasion.

  1989cited by this paper
• Inhibition by retinoic acid of type IV collagenolysis and invasion through reconstituted basement membrane by metastatic rat mammary adenocarcinoma cells.

  1989cited by this paper

• miR-424-3p promotes metastasis of hepatocellular carcinoma via targeting the SRF-STAT1/2 axis.

  2023cites this paper
• The duality of STAT2 mediated type I interferon signaling in the tumor microenvironment and chemoresistance

  2022cites this paper
• Type I interferon regulates proteolysis by macrophages to prevent immunopathology following viral infection

  2022cites this paper
• Ephrin-B1 Is a Novel Biomarker of Bladder Cancer Aggressiveness. Studies in Murine Models and in Human Samples

  2020cites this paper
• The Prognostic Value of some Epithelial-Mesenchymal Transition Markers and Metastasis-Related Markers in Human Transitional Cell Carcinoma of the Bladder

  2018cites this paper
• Behavioral Symptoms of Anxiety and Depression and Brain Monoamine Contents in Rats after Chronic Intranasal Administration of Interferon-α

  2018cites this paper
• Regulation of Extracellular Matrix Remodeling and Epithelial-Mesenchymal Transition by Matrix Metalloproteinases: Decisive Candidates in Tumor Progression

  2017cites this paper
• The Role of MMP9 and WNT Signaling in Peritoneal Angiogenesis

  2017cites this paper
• The Impact of Wound Inflammation on Cancer Progression: Studies in Fish and Patients

  2017cites this paper
• Anti‐metastatic functions of type 1 interferons: Foundation for the adjuvant therapy of cancer

  2017cites this paper
• Inhibition of growth, migration and invasion of human bladder cancer cells by antrocin, a sesquiterpene lactone isolated from Antrodia cinnamomea, and its molecular mechanisms.

  2016cites this paper
• The role of WNT signalling in urothelial cell carcinoma.

  2015cites this paper
• Advances in Protein Chemistry

  2013cites this paper
• Diagnostic impact of promoter methylation and E-cadherin gene and protein expression levels in laryngeal carcinoma

  2013cites this paper
• Epithelial-mesenchymal transition, a novel target of sulforaphane via COX-2/MMP2, 9/Snail, ZEB1 and miR-200c/ZEB1 pathways in human bladder cancer cells.

  2013cites this paper
• Potential of Interferon-α in Solid Tumours

  2012cites this paper
• Potential of Interferon-α in Solid Tumours

  2012cites this paper
• Rational Design and Development of Anti- Angiogenic Protein Agents

  2011cites this paper
• Loss of heterozygosis on IFN-alpha locus is a prognostic indicator of bacillus Calmette-Guerin response for nonmuscle invasive bladder cancer.

  2010cites this paper
• Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer

  2009cites this paper
• Synergistic Effect of Diosmin and Interferon-α on Metastatic Pulmonary Melanoma

  2009cites this paper
• and diosmin on metastasic murine-lung melanoma

  2008cites this paper
• MOLECUL AR PATHOLOGY OF THE GENITOURINARY TRA C T: PROSTATE AND BL ADDER

  2008cites this paper
• Expression of extracellular matrix metalloproteinase (MMP-9), E-cadherin and proliferation-associated antigen Ki-67 and their reciprocal correlation in canine mammary adenocarcinomas.

  2008cites this paper
• Inhibitory effect of interferon-alpha-2b on expression of cyclooxygenase-2 and vascular endothelial growth factor in human hepatocellular carcinoma inoculated in nude mice.

  2008cites this paper
• Efectos del IFN α y la diosmina en el melanoma metastásico pulmonar murino

  2008cites this paper
• Molecular Pathology of the Genitourinary Tract: Prostate and Bladder.

  2008cites this paper
• Enhancing anti-tumor immunity to MHC class I-deficient tumors: role of regulatory T cells and type I IFN

  2008cites this paper
• The Type I Interferon System With Emphasis on Its Role in Malignancies

  2007cites this paper
• Anecortave acetate for the treatment of exudative age-related macular degeneration--a review of clinical outcomes.

  2007cites this paper
• Recombinant Human IFN-β Affects Androgen Receptor Level, Neuroendocrine Differentiation, Cell Adhesion, and Motility in Prostate Cancer Cells

  2007cites this paper
• Enhancing the anti-angiogenic action of histone deacetylase inhibitors

  2007cites this paper
• Molecular therapeutic targets for bladder cancer '….bladder cancer represents a unique model for implementation of multiple molecular therapies owing to the varied drug delivery options.'

  2007cites this paper
• The prognostic value of E‐cadherin, α‐, β‐ and γ‐catenin in bladder cancer patients who underwent radical cystectomy

  2007cites this paper
• The prognostic value of E-cadherin, alpha-, beta- and gamma-catenin in bladder cancer patients who underwent radical cystectomy.

  2007cites this paper
• An Interferon α2 Mutant Optimized by Phage Display for IFNAR1 Binding Confers Specifically Enhanced Antitumor Activities*

  2007cites this paper
• Gene Therapy with Interferon Alpha and the Angiogenic Inhibitor, Vasostatin, in Neuroendocrine Tumors of the Digestive System

  2007cites this paper
• Molecular therapeutic targets for bladder cancer

  2007cites this paper
• In Silico Genomic Analysis of the Human and Murine Guanylate-Binding Protein (GBP) Gene Clusters

  2006cites this paper
• Update on endogenous inhibitors of angiogenesis.

  2006cites this paper
• Cytokine-dependent invasiveness in B16 murine melanoma cells: role of uPA system and MMP-9.

  2006cites this paper
• Matrix metalloproteinases as therapeutic targets in cancer.

  2005cites this paper
• Interferon-mediated anti-angiogenic therapy for neuroblastoma.

  2005cites this paper
• Interferons in the treatment of solid tumors.

  2005cites this paper
• METALLOPROTEINASES AND HUMAN CANCER CELLS

  2005cites this paper
• Urothelial tumorigenesis: a tale of divergent pathways

  2005cites this paper
• Adeno-Associated Virus Vector-Mediated Systemic Delivery of IFN-β Combined with Low-Dose Cyclophosphamide Affects Tumor Regression in Murine Neuroblastoma Models

  2005cites this paper
• Bladder carcinoma: understanding advanced and metastatic disease with potential molecular therapeutic targets

  2005cites this paper
• Effect of bisphosphonates and small cyclic peptides on matrix metalloproteinases and human cancer cells

  2005cites this paper
• The relative endogenous expression levels of the IFNAR2 isoforms influence the cytostatic and pro-apoptotic effect of IFNalpha on pleomorphic sarcoma cells.

  2005cites this paper
• Matrix metalloproteinases in cancer: comparison of known and novel aspects of their inhibition as a therapeutic approach

  2005cites this paper
• Restriction of neuroblastoma angiogenesis and growth by interferon-alpha/beta.

  2004cites this paper
• Role of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand in Interferon-Induced Apoptosis in Human Bladder Cancer Cells

  2004cites this paper
• Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies.

  2004cites this paper
• Interferon receptor expression regulates the antiproliferative effects of interferons on cancer cells and solid tumors

  2004cites this paper
• Antiproliferative Effects of Interferon-αCon1 on Ovarian Clear Cell Adenocarcinoma In vitro and In vivo

  2004cites this paper
• Correlation of metastasis related gene expression and relapse-free survival in patients with locally advanced bladder cancer treated with cystectomy and chemotherapy.

  2004cites this paper
• Restriction of neuroblastoma angiogenesis and growth by interferon-α/β

  2004cites this paper
• Integrating basic science and clinical research in bladder cancer: update from the first bladder Specialized Program of Research Excellence (SPORE)

  2004cites this paper
• Down-regulation of matrix-invasive potential of human liver cancer cells by type I interferon and a histone deacetylase inhibitor sodium butyrate.

  2004cites this paper
• Cadherins in cancer.

  2004cites this paper
• Is Interferon γ One Key of Metastatic Potential Increase in Human Bladder Carcinoma

  2003cites this paper
• Gene products involved in metastasis of bladder cancer.

  2003cites this paper
• Matrix Metalloproteinase-9 Silencing by RNA Interference Triggers the Migratory-adhesive Switch in Ewing's Sarcoma Cells*

  2003cites this paper
• Is interferon gamma one key of metastatic potential increase in human bladder carcinoma?

  2003cites this paper
• Cytokines and Antitumor Immunity

  2003cites this paper
• Matrix metalloproteinases and tumor progression.

  2003cites this paper
• Novel approaches with targeted therapies in bladder cancer. Therapy of bladder cancer by blockade of the epidermal growth factor receptor family.

  2003cites this paper
• Nonviral cytokine gene therapy on an orthotopic bladder cancer model.

  2003cites this paper
• Angiogenic factors and bladder cancer.

  2002cites this paper
• The prognostic value of angiogenesis and metastasis-related genes for progression of transitional cell carcinoma of the renal pelvis and ureter.

  2002cites this paper
• [Molecular markers of infiltrating cancer of the bladder].

  2002cites this paper
• Strategies for MMP inhibition in cancer: innovations for the post-trial era

  2002cites this paper
• Potential of interferon-alpha in solid tumours: part 2.

  2002cites this paper
• Inhibition of Growth and Metastasis of Orthotopic Human Prostate Cancer in Athymic Mice by Combination Therapy with Pegylated Interferon-- 2 b and Docetaxel

  2002cites this paper
• Biochemistry and Molecular Biology of Gelatinase B or Matrix Metalloproteinase-9 (MMP-9)

  2002cites this paper
• Interferons Inhibit Tumor Necrosis Factor-α-mediated Matrix Metalloproteinase-9 Activation via Interferon Regulatory Factor-1 Binding Competition with NF-κB*

  2002cites this paper
• Marqueurs moléculaires du cancer infiltrant de la vessie

  2002cites this paper
• Inhibition of growth and metastasis of orthotopic human prostate cancer in athymic mice by combination therapy with pegylated interferon-alpha-2b and docetaxel.

  2002cites this paper
• Interferons inhibit tumor necrosis factor-alpha-mediated matrix metalloproteinase-9 activation via interferon regulatory factor-1 binding competition with NF-kappa B.

  2002cites this paper